• English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
On February 27, the Nigerian Upstream Petroleum Regulatory Commission (NUPRC) said yesterday that the countrys crude oil production has increased by more than 70% since 2021. The agencys CEO, Engr. Gbenga Komolafe, said that "production has increased from 1 million barrels per day in 2021 to around 1.75 million barrels per day at present." Nigerias oil and gas industry is the core of the economy, contributing 95% of foreign exchange earnings and 70% of government revenue. Komolafe also said that although Nigerias current daily production is 1.75 million barrels, the countrys technical potential is 2.24 million barrels per day. According to him, the commission is working to narrow the gap between actual production and potential. "The potential for increased production is huge, and NUPRC is committed to unlocking every opportunity," Komolafe said.Most of the interbank repo rates rose. FDR001 fell 1.0 basis points to 1.89%; FDR007 rose 5.0 basis points to 2.35%; FDR014 rose 10.0 basis points to 2.35%.Hong Kong-listed catering stocks continued to strengthen, with Nayukis Tea (02150.HK) up more than 40%, Xiabu Xiabu (00520.HK) up more than 16%, Helens (09869.HK) up nearly 10%, Jiu Mao Jiu (09922.HK) up 6.5%, and Haidilao (06862.HK) up more than 5%.Pentagon memo: U.S. service members with gender identity disorder will be removed from the military unless they receive a waiver.February 27th news, in the past half month, two drafts for comments on "drug prices" have been hotly discussed in the industry. The two documents are "Opinions on Improving the Drug Price Formation Mechanism" and "Several Measures on Medical Insurance Supporting the High-quality Development of Innovative Drugs". Among them, the "Opinions" not only focus on the price of innovative drugs, but also include the price of centralized procurement drugs, etc., which is for the full-caliber, full-cycle, and full-channel management of drug prices. "Several Measures" focuses on the support of medical insurance for innovative drugs. The two documents jointly depict the future of innovative drugs, suggesting that the medical insurance negotiation price will no longer be the only price in the future market-perhaps the payment scenario where medical insurance payment belongs to medical insurance payment, self-payment belongs to self-payment, and commercial insurance belongs to commercial insurance will come.

Gold Price Prediction: The XAU/USD pair aims to extend its climb above $1,920 as the Federal Reserve softens its policy tightening tempo

Alina Haynes

Jan 16, 2023 10:50

截屏2023-01-16 上午10.41.37.png 

 

In the early Asian session on Monday, the gold price (XAU/USD) moved sideways following a mammoth rally to the important resistance of $1,920.00. After breaching the $1,900 round-level barrier for the first time in eight months, the precious metal attracted considerable buying interest. In addition, a decline in the US Dollar Index (DXY) boosted the Gold price.

 

The risk profile remains optimistic as the S&P500 has posted a four-day winning run and the Federal Reserve (Fed) is expected to reduce the pace of its current policy tightening in response to a decrease in December's inflation data. Despite the risk appetite trend, the yield on US Treasury bonds has increased to 3.50 percent and remains strong. Despite Friday's rise in U.S. Consumer Confidence numbers, the US Dollar Index stayed below 101.80.

 

The University of Michigan announced a Consumer Confidence reading of 64,6 as opposed to the anticipated 60.5. The street is aware that retail demand has slowed, thus the factor that has encouraged customers is the decrease in inflation caused by decreased gasoline costs.

 

Wells Fargo analysts observe that the respite on the inflation front and wage growth are boosting sentiment, but they caution that the still-sour buying conditions suggest the positive sentiments in this report may not transfer into a spending spree.

 

At $1,897.42, the gold price has surpassed the 61.8% Fibonacci retracement (set from March 8's high of $2,070.54 to September 28's low of $1,614.85) Upward-sloping 10- and 20-period Exponential Moving Averages (EMAs) at $1,881.49 and $1,856.40, respectively, contribute to the upward filters.